HOME >> BIOLOGY >> NEWS
Alterations in vitamin D receptor gene increase prostate, breast cancer risk

Subtle differences in the receptor for vitamin D reverse the anti-cancer action of the sunshine vitamin, increasing the risk of breast cancer in Caucasian women and prostate cancer in African-American men, according to two new studies.

The results, in journals published by the American Association for Cancer Research, underscore how naturally-occurring variants of the same gene, called polymorphisms, can have implications for cancer initiation and progression.

For example, in the breast cancer study, British scientists at St. George's Hospital Medical School in London found that Caucasian women who carried specific versions of the vitamin D receptor gene, or VDR, not only experienced increased risk for this cancer but may also be more prone to developing metastases.

"Differences in the gene sequence for the vitamin D receptor are associated with breast cancer risk and may also be linked to disease progression" said Kay Colston, Ph.D., the senior author of the study, published in the August 15 issue of Clinical Cancer Research. Colston is a Reader in the Department of Cellular and Molecular Medicine at St. George's Hospital Medical School.

Among three known variable regions of the VDR gene considered by the research team, the bb and LL variants increased breast cancer risk by almost twofold. The F variant of the gene had no significant effect on breast cancer risk by itself, however when coupled with the LL genotype the risk of breast cancer was increased by a higher factor than the bb or LL genotypes alone. In addition, there was a higher proportion of women with this 'at risk' genotype in a sub-group of patients who developed metastatic disease.

A second study, conducted independently, linked a similar change in the vitamin D receptor (VDR) with amplified risk of prostate cancer for African American men. That study appeared in the August issue of Cancer Epidemiology, Biomarkers & Prevention, a sister publication to Clinic
'"/>

Contact: Russell Vanderboom, PhD
vanderboom@aacr.org
215-440-9300
American Association for Cancer Research
6-Aug-2004


Page: 1 2

Related biology news :

1. Genetic Alterations Linked To Cancer In Some Blood Samples
2. Lycopene slows human prostate tumour growth in mice and combined with vitamin E is even better
3. Chemical derived from vitamin-E shows early promise as cancer drug
4. Folic acid vitamin use by women reaches all-time high, March of Dimes survey finds
5. Could vitamins raise levels of bad cholesterol? Animal study suggests they might
6. New antioxidants are 100 times more effective than vitamin E
7. Study finds huge variability in vitamin E absorption
8. People with undetermined muscle/bone pain tend to be severely vitamin D deficient
9. Daily vitamins could prevent vision loss among thousands
10. Drug that mimics vitamin D hormone may boost effectiveness of prostate cancer treatment
11. Strategies to boost womens multivitamin use fall short

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), ... multiple awards for not only the products and treatments developed, but also the ... Microneedle RF. All the brands built by ABM have received several honors already ...
(Date:7/1/2020)... VENICE, Calif. (PRWEB) , ... July 01, 2020 ... ... focused on building awareness and solutions for glioblastoma—the most common and aggressive adult ... and Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that the company has received ISO9001:2015 certification for the development ... research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions ... live webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , ... for medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) ...
(Date:7/18/2020)... (PRWEB) , ... July 16, 2020 , ... ... solutions to aid in the early detection and prevention of high-burden diseases, and ... enable US-based hospitals and healthcare organizations to utilize existing data in order to ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... Technology (MIT) has expanded the company’s exclusive license to include clinical applications ... point-of-care diagnostic market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast ...
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 06, 2020 , ... R3 ... new program featuring up to 200 million stem cells. Depending on the patient's condition, ... seniors in the US will die having some form of Alzheimers dementia, and the ...
Breaking Biology Technology:
Cached News: